-
Product Insights
New![]()
TB Flats Wind Energy Project
TB Flats Wind Energy Project is an Onshore Wind project located in Wyoming, United States. The project is owned by PacifiCorp and was developed by Invenergy Wind Development LLC; Rocky Mountain Power. The project came online in 2021. Empower your strategies with our TB Flats Wind Energy Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
New![]()
TBS Hldg – Binh Duong Green Tower – Binh Duong
Equip yourself with the essential tools needed to make informed and profitable decisions with our TBS Hldg – Binh Duong Green Tower – Binh Duong report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough understanding of...
-
Company Insights
New![]()
Innovation and Patenting activity of TBS Holdings Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of TBS Holdings Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TB-796 in Sarcopenia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TB-796 in SarcopeniaDrug Details:TB-796 is under development for the treatment of sarcopenia. The drug candidate is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TB-006 in Alzheimer’s Disease
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TB-006 in Alzheimer's Disease Drug Details: TB-006 is under development for the treatment of...
-
Product Insights
New![]()
Tangshan TB – Qinhuangdao-Tangshan Expressway: Tanggang to Hebei-Tianjin Boundary Section – Hebei
Equip yourself with the essential tools needed to make informed and profitable decisions with our Tangshan TB – Qinhuangdao-Tangshan Expressway: Tanggang to Hebei-Tianjin Boundary Section – Hebei report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Bedaquiline Fumarate in Leprosy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Bedaquiline Fumarate in Leprosy Drug Details: Bedaquiline Fumarate (Sirturo) is a diarylquinoline antimycobacterial drug. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ruti in Pulmonary Tuberculosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.RUTI in Pulmonary Tuberculosis Drug Details:RUTI is under development for the treatment of latent tuberculosis (TB),...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RUTI in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. RUTI in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Drug Details: RUTI is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GSK-3536852A in Bacillary Dysentery (Shigellosis)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.GSK-3536852A in Bacillary Dysentery (Shigellosis)Drug Details:GSK-3536852A is under development for the prevention of Shigellosis. The vaccine...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.